Acute Pancreatitis Ap clinical trials

Explore recruiting acute pancreatitis ap clinical trials.

Recruiting acute pancreatitis ap studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Pancreatitis Ap trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults with Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis (SHASTA-5 Study)

Hungary, Bulgaria, Sweden, Austria, Norway, Belgium +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

COPE-CP: The effect of Celecoxib on pain, quality of life, use of opioids, and inflammation in patients suffering from chronic pancreatitis: a multicenter randomized placebo-controlled, double-blinded clinical trial

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Acute Pancreatitis Ap trials by city

Acute Pancreatitis Ap in Toronto Acute Pancreatitis Ap in Vancouver Acute Pancreatitis Ap in Montreal Acute Pancreatitis Ap in Calgary Acute Pancreatitis Ap in Edmonton Acute Pancreatitis Ap in Ottawa Acute Pancreatitis Ap in Winnipeg Acute Pancreatitis Ap in Quebec City Acute Pancreatitis Ap in Hamilton Acute Pancreatitis Ap in Kitchener Acute Pancreatitis Ap in London Acute Pancreatitis Ap in Halifax Acute Pancreatitis Ap in New York Acute Pancreatitis Ap in Los Angeles Acute Pancreatitis Ap in Chicago Acute Pancreatitis Ap in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease